Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering

The skin recovery emulsion for dry, sensitive, or stressed skin is now available through select online channels

BHC.TO : 7.85 (-0.51%)
BHC : 5.68 (-0.70%)
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026

LAVAL, QC , March 31, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter 2026 financial results after market close on Wednesday, April 29, 2026. Bausch...

BHC.TO : 7.85 (-0.51%)
BHC : 5.68 (-0.70%)
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with applications open through June 2026

BHC.TO : 7.85 (-0.51%)
BHC : 5.68 (-0.70%)
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada

LAVAL, QC , Feb. 23, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in medical aesthetics,...

BHC.TO : 7.85 (-0.51%)
BHC : 5.68 (-0.70%)
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres

The only FDA‑approved locally applied antibiotic used with scaling and root planing (SRP) marks a quarter‑century of clinical use

BHC.TO : 7.85 (-0.51%)
BHC : 5.68 (-0.70%)
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program

Bausch Health to Provide Scholarships to 10 Students Living with GI Diseases

BHC.TO : 7.85 (-0.51%)
BHC : 5.68 (-0.70%)
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline

DRRX : 1.9100 (-1.04%)
BHC.TO : 7.85 (-0.51%)
BHC : 5.68 (-0.70%)
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat

Shares of Bausch Health Companies Inc. (BHC) declined 6.3% after the company reported mixed results for the second quarter of 2025.Adjusted earnings per share of 90 cents missed the Zacks Consensus Estimate...

DRRX : 1.9100 (-1.04%)
ARVN : 11.00 (+3.97%)
CRMD : 7.30 (-0.27%)
BHC : 5.68 (-0.70%)
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

LAVAL, QC and CUPERTINO, Calif. , July 29, 2025 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), a global, diversified pharmaceutical company, and DURECT Corporation...

DRRX : 1.9100 (-1.04%)
BHC.TO : 7.85 (-0.51%)
BHC : 5.68 (-0.70%)
New Strong Sell Stocks for May 13th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:AlTi Global, Inc. ALTI is a financial company which provides merchant banking, corporate advisory, brokerage and placement agency...

AMRK : 29.25 (+1.88%)
BHC : 5.68 (-0.70%)
ALTI : 3.79 (-2.07%)

Barchart Exclusives

Dire Straits: This ETF Is a Must-Watch As Rare Earths Become the Real Boondoggle of the Iran War
All eyes have been on the energy and defense sectors amid the Iran war, but rare earths should be investors' focus. Here's why. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.